Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

Ítems similars

• Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein
  per: Sun, Guifeng, et al.
  Publicat: (2009)
• The major outer membrane protein nucleotide sequence of Chlamydia trachomatis, serovar E.
  per: Peterson, E M, et al.
  Publicat: (1990)
• Vaccination with the Recombinant Major Outer Membrane Protein Elicits Antibodies to the Constant Domains and Induces Cross-Serovar Protection against Intranasal Challenge with Chlamydia trachomatis
  per: Tifrea, Delia F., et al.
  Publicat: (2013)
• A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
  per: Cheng, Chunmei, et al.
  Publicat: (2011)
• Induction of protective immunity by vaccination against Chlamydia trachomatis using the major outer membrane protein adjuvanted with CpG oligodeoxynucleotide coupled to the nontoxic B subunit of cholera toxin
  per: Cheng, Chunmei, et al.
  Publicat: (2009)